TrialDiabetic medicine : a journal of the British Diabetic Association2010

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial.

R E Ratner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.